Skip to content

Treatment with sloping treadmill to improve the physical conditioning of people with Stroke

Effects of inclined treadmill on cardiovascular and functional parameters of individuals with Stroke: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5ffbxz
Enrollment
Unknown
Registered
2018-01-25
Start date
2017-08-19
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, not specified as haemorrhage or infarction

Interventions

All the 36 participants will underwent interventions in three groups: Experimental group 1 (12 participants): they will perform treadmill training with 5% anterior slope of treadmill, 30 minutes / day
Other
E02.760.169.063.500.387
E01.370.600.250

Sponsors

Departamento de Fisioterapia da Universidade Federal do Rio Grande do Norte
Lead Sponsor
Departamento de Fisioterapia da Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: The participants will be selected according to the following criteria: diagnosis of the first episode of unilateral stroke (ischemic or hemorrhagic) that resulted in walking deficits; sequelae time equal to or greater than six months; age greater than 20 years and equal to or less than 70 years; ability to walk without personal assistance indoors (FAC scores equal to or greater than 3 (MEHRHOLZ et al., 2007); comfortable walking speed in the ground equal to or less than 0.9 m / s (limited community walkers), according to the classification proposed by Fulk and co-workers (2017); and ability to understand and obey simple motor commands.

Exclusion criteria

Exclusion criteria: Exclusion criteria will include: being in the gestational period; presenting instability in cardiac conditions (uncontrolled heart disease) and / or heart failure (New York Heart Association (NYHA) scores equal to or greater than 3 (REMME & SWEDBERG, 2001); other clinical conditions affecting walking; have severe pain and / or discomfort, which impedes the performance of the proposed activities; presented decompensations in the systemic arterial pressure, with systolic and diastolic values above, respectively, 200mmHg and 110mmHg before and / or after training (BALADY et al., 1998); and heart rate above the submaximal values allowed during training, maintained even after pauses, calculated using the formula [FCsub = 0.75 x (220-age)] (FOX III et al., 1971), where FCsub = submaximal heart rate.

Design outcomes

Primary

MeasureTime frame
Outcome expected 1: Increased gait velocity, verified through ground walking test, comparing pre and post intervention data;Outcome expected 2: Improvement of functional capacity, verified by the increase of the distance covered in the 2-minute walk test, comparing pre and post-intervention data;Outcome expected 3: Improvement of cardiovascular parameters (reduction of blood pressure, reduction of heart rate and increase of oxygen saturation), verified using a sphygmomanometer and cardiofrequencymeter, comparing pre- and post-intervention data

Secondary

MeasureTime frame
Outcome expected 4: Increased neuromuscular torque, verified by means of evaluation with isokinetic dynamometry, with quadriceps torque increase bilaterally, comparing pre- and post-intervention data;Outcome expected 5: Improvement of the quality of life, verified through the increase of the scale of evaluation of quality of life in stroke (SSQoL), comparing pre- and post-intervention data

Countries

Brazil

Contacts

Public ContactTatiana Ribeiro

Universidade Federal do Rio Grande do Norte

ribeiro_tatiana@outlook.com+55-84-33422010

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 3, 2026